These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25581586)
1. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'. Nijsten T Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586 [No Abstract] [Full Text] [Related]
2. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'. Arits A; Nelemans P; Kelleners-Smeets N Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585 [No Abstract] [Full Text] [Related]
3. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal. Lecluse LL; Spuls PI Br J Dermatol; 2015 Jan; 172(1):8-10. PubMed ID: 25581584 [TBL] [Abstract][Full Text] [Related]
5. Effect of pigmentation on photodynamic therapy. Apalla Z; Lallas A; Sotiriou E; Ioannides D Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270 [No Abstract] [Full Text] [Related]
7. Treating basal-cell carcinoma in a real life setting. Dummer R Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843 [TBL] [Abstract][Full Text] [Related]
9. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU). Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596 [TBL] [Abstract][Full Text] [Related]
10. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128 [No Abstract] [Full Text] [Related]
11. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012 [TBL] [Abstract][Full Text] [Related]
12. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma. Sotiriou E; Apalla Z; Ioannides D Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170 [No Abstract] [Full Text] [Related]
13. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820 [TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study. Christensen E Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763 [No Abstract] [Full Text] [Related]
15. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437 [TBL] [Abstract][Full Text] [Related]
16. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. van Delft LCJ; Nelemans PJ; Jansen MHE; Arits AHMM; Roozeboom MH; Hamid MA; Mosterd K; Kelleners-Smeets NWJ J Am Acad Dermatol; 2019 Apr; 80(4):1022-1028. PubMed ID: 30582993 [TBL] [Abstract][Full Text] [Related]
17. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy. Park MY; Kim YC Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909 [No Abstract] [Full Text] [Related]